Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.
Average price paid is weighted by shares, so a large purchase counts for more than a small one. It is what insiders reported paying, not a target or a fair value.
Insider flow: Buying only — a count of disclosed transactions, not a rating or a recommendation.
Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.
Share-weighted average price across 4 reported purchases, with the full range of prices paid. Purchases only — averaging a sale into an "insider cost" would describe a price nobody paid.
One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.
The filings above are public record and stay public here. What an account adds for $CTM is the reading of them — and for this company, that is what the list below says it is, no more.
Not available for CTM today: no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.
A free account opens all of it.
Every open-market transaction disclosed for CTM in the synced window. Values are the insider's own, as filed.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-10-01 | MARTIN TAMMY L | General Counsel and Secretary | Open-market buy | 1,396 | 0.54 | $747 |
| 2026-10-01 | Ives Glen R | President, Director, Chief Executive Officer | Open-market buy | 1,700 | 0.54 | $910 |
| 2026-10-01 | Merriman Andrew | Chief Operating Officer | Open-market buy | 1,396 | 0.54 | $747 |
| 2026-10-01 | Bell David T | Chief Financial Officer, Treasurer | Open-market buy | 1,396 | 0.54 | $747 |
Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.